Recruiting Breast Cancer Studies in Brewer
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
This research study is studying a combination of HER2-directed therapies (trastuzumab and pertuzumab) and hormonal therapy as a treatment after surgery for hormone receptor positive breast cancer. Th...
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts ...
About Breast Cancer Clinical Trials in Brewer
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Brewer, MAINE. These studies are seeking a combined 485 participants. Research is being sponsored by Dana-Farber Cancer Institute. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Brewer — FAQ
Are there breast cancer clinical trials in Brewer?
Yes, there are 2 breast cancer clinical trials currently recruiting in Brewer, MAINE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Brewer?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Brewer research site will contact you about next steps.
Are clinical trials in Brewer free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Brewer studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Brewer are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov